Perkin-Elmer To Introduce New Instrument Based On Breakthrough DNA Analysis Technology

NORWALK, Conn., May 9, 1998 -- The Perkin-Elmer Corporation (NYSE: PKN) announced today that it was nearing the end of development of a breakthrough DNA analysis technology that should enable the generation of sequencing data at an ultra-high throughput level. The Company is designing the 3700 DNA Analyzer to provide the catalyst for a major new genomics initiative. While production shipments are scheduled for the first quarter of calendar year 1999, Perkin-Elmer expects to shortly announce an early access program for customers interested in becoming test sites for the instrument late in calendar year 1998.

As reported in a separate news announcement made today, Perkin-Elmer, genomics pioneer Dr. J. Craig Venter, and The Institute for Genomic Research (TIGR) have signed letters of intent relating to the formation by Perkin-Elmer and Dr. Venter of a new genomics company which will be a beta test site for the instrument. The new company's strategy will be centered on a plan to substantially complete the sequencing of the human genome in three years.

The 3700 DNA Analyzer, to be priced at approximately $300,000, is the first model of a new product category in DNA sequencing and genetic analysis that is designed to enable applications requiring tens of thousands of samples produced weekly. This production-scale instrument will be marketed with the current 377 and 310 instruments as part of the ABI PRISM family of genetic analysis instruments. The 3700 DNA Analyzer, under development at the Applied Biosystems Division of Perkin-Elmer, combines proven capillary electrophoresis hardware and separation polymer chemistry, with new detection technology and automation.

The 3700 DNA Analyzer is designed for customers who require:

  • Ultra-high throughput
  • 24-hour, multi-run unattended automation, including gel-pouring and sample loading
  • Operating costs that meet the requirements of very large projects such as the completion of

Contact: Timothy Sipols
212-696-4455 x 272
Noonan/Russo Communications

Page: 1 2 3

Related biology news :

1. Perkin-Elmer, Dr. J. Craig Venter, And TIGR Announce Formation Of New Genomics Company
2. Introduced marine species get larger in the invaded region
3. Unveiling all of the consequences: Introduced plants may be causing hidden trouble
4. NCAR Scientists, Aircraft, Instruments Head To Indian Ocean For Climate ChangeExperiment; UCAR Directs Operations
5. Fullerene-Based Materials Clear From Tissue, Go To The Bone
6. Plant-Based Fat Inhibits Growth Of Breast-Cancer Cell Line, UB Researchers Show
7. Plant-Based Fat May Reduce Risk Of Prostate Cancer By Altering Testosterone Metabolism, UB Study Shows
8. NASA Exhibit, Experts To Be In Baltimore Focusing On Space Research Improving Earth-Based Health Care
9. Educators Launch Internet Based Workshop On Pollution Prevention
10. UCSF Researchers Identify Key Genes In Bone Healing Process That Could Lead To New, Molecular-Based Treatments
11. Wood-Based Composites Center Established At Virginia Tech

Post Your Comments:

(Date:4/12/2019)... ... April 11, 2019 , ... Neal O’Farrell is one of the first ... He is executive director of the consumer advocacy non-profit the Identity Theft Council as ... member of the Federal Communications Commission’s Cybersecurity Roundtable and is currently a fellow of ...
(Date:4/5/2019)... AUBURN, Mass. (PRWEB) , ... April 04, 2019 ... ... family is available with integrated linear encoders providing 0.05 microns and 0.005 microns ... prices. Many motor and drive variations are available, from fast DC-servo motors with ...
(Date:4/4/2019)... ... 03, 2019 , ... R3 Stem Cell is now offering ... of Excellence. R3 wants patients to feel secure when they make a significant ... Centers that use inferior regenerative biologics, protocols or amounts, R3 provides a safe ...
Breaking Biology News(10 mins):
(Date:4/9/2019)... ... April 09, 2019 , ... ... the capacity of life sciences organizations to accelerate innovation and maximize productivity, announces ... in the past 12 months. , USDM’s Cloud Assurance is a ...
(Date:4/8/2019)... (PRWEB) , ... April 08, 2019 , ... US ... investors a $15 million preferred equity investment in the privately held pharmaceutical company, S1 ... leading drug, Lorexys, is targeted at female hypoactive sexual dysfunction disorder and is ready ...
(Date:3/29/2019)... ... March 28, 2019 , ... ... testing milestones, CARB-X has proceeded with a second stage of funding for Specific’s ... million, which is on top of the $1.7 million already awarded by CARB-X. ...
(Date:3/23/2019)... (PRWEB) , ... March 22, 2019 , ... ... sample collection, and analysis to a team of researchers at Nnamdi Azikiwe University ... by Dr. Nneka R. Agbokoba, PhD, of the Department of Medical Laboratory Sciences ...
Breaking Biology Technology:
Cached News: